Skip to main content
. 2018 Nov 13;17(1):1299–1305. doi: 10.3892/ol.2018.9694

Figure 2.

Figure 2.

Overall survival rates for patients in different T subgroups. According to mixed analysis of the five groups, the 5-year survival rate was 84.6% for T1, 72.3% for T2, 44.7% for T3, 37.9% for T4a and 27.3% for T4b. P<0.001. T, tumor depth.